Clinical Trials · NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 2,115
- Start date
- Dec 2026
- Locations
- 155 sites, 9 countries
- Primary endpoint
- Percent Change from Baseline in Body Weight